Publications by authors named "Ellison Suthoff"

Claim this Profile
T
The magnitude and sustainability of treatment benefit of zuranolone on function and well-being as assessed by the SF-36 in adult patients with MDD and PPD: An integrated analysis of 4 randomized clinical trials.
Anita H Clayton, Ellison Suthoff, Rakesh Jain, Mark Kosinski, Moshe Fridman

J Affect Disord· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Economic Burden of Adults with Major Depressive Disorder in the United States (2019).
Paul Greenberg, Abhishek Chitnis, Derek Louie, Ellison Suthoff, Shih-Yin Chen

Adv Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of early remission on disease trajectory and patient outcomes in major depression disorder (MDD): A targeted literature review and microsimulation modeling approach based on the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study.
Alix Arnaud, Jennifer Benner, Ellison Suthoff, Brian Werneburg, Marcia Reinhart

J Affect Disord· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Treating Depression on Associated Comorbidities: A Systematic Literature Review.
Alix M Arnaud, Teri S Brister, Ken Duckworth, Phyllis Foxworth, Tonya Fulwider, Ellison D Suthoff

Prim Care Companion CNS Disord· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation.
Gregory S Sawicki, Michael W Konstan, Edward F McKone, Richard B Moss, Barry Lubarsky, Ellison Suthoff

Pulm Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden and antidepressant treatment patterns among patients with major depressive disorder in the United States.
Ling Zhu, Erin Ferries, Ellison Suthoff, Madhav Namjoshi, Rimal Bera

J Manag Care Spec Pharm· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Major Depressive Disorder on Comorbidities: A Systematic Literature Review.
Alix M Arnaud, Teri S Brister, Ken Duckworth, Phyllis Foxworth, Tonya Fulwider, Ellison D Suthoff

J Clin Psychiatry· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humanistic and economic burden associated with depression in the United States: a cross-sectional survey analysis.
Saundra Jain, Shaloo Gupta, Vicky W Li, Ellison Suthoff, Alix Arnaud

BMC Psychiatry· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder.
Ellison Suthoff, Mark Kosinski, Alix Arnaud, Paul Hodgkins, Handan Gunduz-Bruce

J Affect Disord· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Increasing Economic Burden with Additional Steps of Pharmacotherapy in Major Depressive Disorder.
Alix Arnaud, Ellison Suthoff, Rita M Tavares, Xuan Zhang, Aditi J Ravindranath

Pharmacoeconomics· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Number Needed to Treat and Number Needed to Harm analysis of the zuranolone phase 2 clinical trial results in major depressive disorder.
Alix Arnaud, Ellison Suthoff, Katie Stenson, Brian Werneburg, Paul Hodgkins

J Affect Disord· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cystic Fibrosis Impact Questionnaire: qualitative development and cognitive evaluation of a new patient-reported outcome instrument to assess the life impacts of cystic fibrosis.
Kelly P McCarrier, Mariam Hassan, Paul Hodgkins, Ellison Suthoff, Lisa J McGarry

J Patient Rep Outcomes· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caregiver Burden Due to Pulmonary Exacerbations in Patients with Cystic Fibrosis.
Ellison Suthoff, Jochen G Mainz, Desmond W Cox, Teja Thorat, Daniel H Grossoehme

J Pediatr· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring recovery in health-related quality of life during and after pulmonary exacerbations in patients with cystic fibrosis.
Patrick A Flume, Ellison D Suthoff, Mark Kosinski, Gautham Marigowda, Alexandra L Quittner

J Cyst Fibros· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in patients with cystic fibrosis with a G551D mutation on ivacaftor treatment: results from a cross-sectional study.
Scott C Bell, Jochen G Mainz, Gordon MacGregor, Susan Madge, Julie Macey, Ellison D Suthoff

BMC Pulm Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization associated with ivacaftor use in patients with cystic fibrosis.
Ellison D Suthoff, Mac Bonafede, Brendan Limone, Lasair O'Callaghan, Gregory S Sawicki

J Med Econ· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation: patient-reported outcomes in the STRIVE randomized, controlled trial.
Alexandra Quittner, Ellison Suthoff, Regina Rendas-Baum, Martha S Bayliss, Isabelle Sermet-Gaudelus

Health Qual Life Outcomes· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes.
Alan Oglesby, Caroline Korves, François Laliberté, Gregory Dennis, Sapna Rao, Ellison Dial Suthoff

Appl Health Econ Health Policy· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and treatment patterns of angiogenesis inhibitors in patients with advanced renal cell carcinoma in Spain.
Daniel Castellano, Mei Sheng Duh, Caroline Korves, Ellison Dial Suthoff, Maureen Neary

Expert Opin Drug Saf· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis